Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 11.6B | 11.6B | 13.4B | 11.0B |
Cost of revenue | 9.3B | 9.2B | 9.7B | 8.4B |
Gross profit | 2.3B | 2.4B | 3.7B | 2.7B |
Operating expense | ||||
Research & development | — | 193.7M | — | 254.8M |
Selling general and admin | 3.3B | 547.6M | 2.9B | 642.7M |
Other operating expenses | — | 40.1M | — | 42.3M |
Operating income | 2.3B | 22.3M | 772.3M | 54.0M |
Non operating interest income | ||||
Income | — | 178.2M | — | 87.5M |
Expense | — | 22.0M | — | 18.6M |
Other income expense | — | — | — | — |
Pretax income | -861.0M | 164.0M | 870.7M | 130.5M |
Tax provision | -1.7M | -311.3M | 184.4M | 26.6M |
Net income | -859.3M | 475.3M | 686.3M | 104.0M |
Basic EPS | -230.8 | — | 181 | 28 |
Diluted EPS | -230.8 | — | 181 | 28 |
Basic average shares | — | — | 3.8M | 3.7M |
Diluted average shares | — | — | 3.8M | 3.7M |
EBITDA | 2.3B | 526.3M | 772.3M | 432.4M |
Net income from continuing op. | — | 475.3M | — | 104.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |